Cytosorbents Corporation (CTSO)

Cytosorbents Stock Forecast

Stock Price Forecast

The 2 analysts that cover Cytosorbents stock have a consensus rating of "Buy" and an average price target of $5.38, which forecasts a 796.52% increase in the stock price over the next year. The lowest target is $0.75 and the highest is $10.

Price Target: $5.38 (+796.52%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$0.75	$5.38	$10	$10
Change	+24.98%	+796.52%	+1566.4%	+1566.4%

Analyst Ratings

The average analyst rating for Cytosorbents stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	1	1	1	1	1	1
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $10	Strong Buy	Maintains	$10	+1,566.39%	Mar 26, 2026
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $10	Strong Buy	Maintains	$10	+1,566.39%	Jan 12, 2026
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $10	Strong Buy	Maintains	$10	+1,566.39%	Dec 16, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $10	Strong Buy	Maintains	$10	+1,566.39%	Nov 14, 2025
Sean Lee HC Wainwright & Co.	HC Wainwright & Co.	Hold Maintains $1 → $0.75	Hold	Maintains	$1 → $0.75	+24.98%	Nov 14, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

41.59M

Increased by 12.21%

from 37.06M

Revenue Next Year

50.06M

Increased by 20.37%

from 41.59M

EPS This Year

-2.84

from -0.13

EPS Next Year

-0.06

from -2.84

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	43.17M	34.69M	31.08M	35.59M	37.06M	41.59M	50.06M
Revenue Growth	5.27%	-19.64%	-10.39%	14.51%	4.13%	12.21%	20.37%
EPS	-0.57	-0.75	-0.65	-0.38	-0.13	-2.84	-0.06
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	5	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030
High	43.2M	53.6M
Avg	41.6M	50.1M
Low	39.6M	46.2M

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030
High	16.6%	28.9%
Avg	12.2%	20.4%
Low	6.8%	11.0%

EPS Forecast

EPS	2026	2027
High	-0.16	-0.05
Avg	-2.84	-0.06
Low	-7.84	-0.07

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.